Olix Pharmaceuticals: Clinical trial application rejected
AI reading
★★★★ Bearish · Material event
Regulator rejects clinical trial application
An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).
Other filings by Olix Pharmaceuticals
- 10.08 ★★ Amended: Clears Phase 1b/2a trial of OLX72021 in men with androgenetic hair loss (multicenter, randomized, double-blind, placebo-controlled, multiple ascending dose study of safety and efficacy)
- 09.30 ★★ Amended filing: clinical trial approval request
- 09.16 ★★★ Files for Phase 2a trial of macular degeneration drug OLX10212
- 09.08 ★★ Amended filing: Phase 1b/2a trial request for hair loss drug OLX72021
- 09.01 ★★ Report on major shareholding
- 08.21 ★★★ Signs joint research and technology transfer agreement with Hansoh
For information only. Not investment advice.